#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Contrast Sensitivity and Optic Coherence Tomography Examinations in Adolescent Patients with Diabetes Type I Preretinopathy (A Pilot Study)


Authors: J. Krásný 1;  J. Vosáhlo 2;  J. Čeledová 1;  I. Hora 1;  L. Magera 1;  M. Veith 1
Authors‘ workplace: Oční klinika FN Královské Vinohrady Praha přednosta prof. MUDr. P. Kuchynka, CSc. 1;  Klinika dětí a dorostu FN Královské Vinohrady, Praha přednosta doc. MUDr. Felix Votava, Ph. D. 2
Published in: Čes. a slov. Oftal., 70, 2014, No. 4, p. 123-130
Category: Original Article

Overview

Aim:
To evaluate the development of retinal changes in adolescent patients with diabetes type I (T1DM) with disease’s duration more than 10 years, which started before 5 years of age.

Methods:
The development of the findings on the posterior pole was followed up. The retinal functions were established by means of contrast sensitivity in four space frequencies: 3 cycles/degree (c/deg) (perimacular area), 6 c/deg and 12 c/deg (macular area), and, finally, 18 c/deg (foveola). The central retinal thickness, average retinal thickness of the specified quadrant of macular area, the foveolar depth of its own, and the volume of the perimacular area (perimacular cube volume) were measured by means of optical coherent tomography (OCT).

Material:
Altogether 20 patients with diabetes type I meeting the set criteria were examined, and their findings were compared with control group of healthy adolescent people. The values from the control group were used as our normative database.

Results:
On the retina, there were found, during the disease’s course lasting in average 13.3 years, changes of the macular area, especially tortuosity of macular final capillaries and pigmentation with disappearing of foveolar reflex, which, in 20 %, were followed by sporadic hard exsudates of the retina. Difference of the decreased values in adolescent patients, comparing to the control group, was recorded in contrast sensitivity in space frequencies of 3 c/deg (p 0.047) and 12 c/deg (p 0,0497), but statistically significant was the difference in space frequencies of 6 c/deg (p 0.0001) and 18 c/deg (p 0.0001). Using the OCT, no statistically significant difference was found in the central retinal thickness, but the values of foveolar depth in patients with diabetes type I were variable (p 0.0153); in four eyes it was much deeper, and in other four of them it was much shallower. Furthermore, there was higher the average thickness of the retina (p 0.0008) and the volume of the perimacular area (perimacular cube) (p 0,0001).

Conclusion:
The findings in eight eyes out of five patients with T1DM were evaluated as diabetic preretinopathy – pre-stage of beginning stage of diabetic retinopathy in central area of the retina from the functional and structural point of view of current pathological changes of contrast sensitivity and OCT. The findings of other three patients were rated as diabetic preretinopathy according to sporadic hard exsudates of the retina and OCT changes, but. until now, without contrast sensitivity changes. The one-year profile of glycated hemoglobin (HbA1c) was higher in patients with diabetic preretinopathy than without the eye involvement, but it was not statistically significant (p 0,0314).

Key words:
Contrast sensitivity (CS), Spectral Domain Optic Coherence Tomography (SD-OCT), diabetes mellitus type I (T1DM), diabetic preretinopathy (DpR), glycated hemoglobin (HbA1c)


Sources

1. Asefzadeh, B., Fisch, B.M. et al.: Macular Thickness and Systemic Markers for Diabetes in Individuals with No or Mild Diabetic Retinopathy. Clin Experiment Ophthalmol, 36, 2008: 455–463.

2. Chalam, K.V., Bressler, S.B. et al.: Retinal Thickness in People with Diabetes and Minimal or No Diabetic Retinopathy: Heidelberg Spectralis Optical Coherence Tomography. Invest. Ophhalmol. Vis Sci, 53, 2012: 8154–8161.

3. Cinek, O, Kulich, M. et. al.: The Incidence of Type 1 Diabetes in Young Czech Children Stopped Rising. Pediatric Diabetes, 13, 2012: 559–563.

4. Danne, t., Mortensen, H.B. et al.: Persistent Differences Amog Centers over 3 Yeaers in Study of 3.805 Chilren and Adolescents with Type 1 Diabetes from the HvidØre Study Group. Diabetes Care, 24, 2001: 1342–47.

5. Diabetes Control and Complications Trial Research Group (DCCCT): The Efffect of Intensive Treatment of Diabetes on tht Development and Progression of Long Term Complications in Insulin-dependent Diabetes Mellitus. N.Engl. J. Med., 329, 1993: 977–986.

6. DeBuc, C.D., Somfai, G.M.: Early Detection of Retinal Thickness Changes in Diabetes Using Optical Coherence Tomography. Med. Sci. Monit., 16, 2010: 15–21.

7. Demir, M., Oba, E. et al.: Central Makulare Thickness in Pacients with Type 2 Diabetes Mellitus without Clinical Retinopathy. BMC Ophtalmol., 13, 2013, April, doi.:10.1186

8. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, Implementation, and Preliminary Results of a Long-term Follow-up of the Diabewtes Control and Complications Trials Cohort., Dabeties Care, 22, 1999: 99–111.

9. EURODIAB Study Group (ed. Patterson C.C.et al.): Incidence Trend for Childhood Type 1 Diabetes in Europe during 1989 – 2003 and Predicted New Cases 2005 – 20: Multicentre Prospective Registration Study. Lancet, 373, 2009: 2027–33.

10. Georgakopoulos, C.D., Eliopoulou, M.I. et. al.: Decreased Contrast Sensitivity in Children and Adolescents with Type 1 Diabetes Mellitus. J. Pediatr. Ophthalmol. Strabismus, 48, 2011: 92–97.

11. Hee, M.R., Puliafito, C.A. et al.: Topography of Diabetic Macular Edema with Optical Coherence Tomography. Ophthalmology, 105, 1998: 360–370.

12. Karel, I., Peleška, M.: Fluorescenční angiografie u pseudoedému zrakového nervu. Čs Oftal, 32, 1976: 275–281.

13. Kalvodová, B., Záhlava, J.: Výsledky vitrektomie u cystoidního makulárního edému v obrazu OCT. Čes a Slov Oftal, 58, 2002: 224–232.

14. Katz, G., Levkovitch-Verbin, H. et al.: Mesoptic Foveolal Contrast Sensitivity Is Impaired in Diabetic Patients without Retinopathy. Graefes Arch. Clin. Exp. Ophthalmol., 248, 2010: 1699–1703.

15. Klein, R., Lee, K.E. et al.: The 25-Year Incidence of Visual Impairment in Type 1 Diabetes Mellitus: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology, 116, 2010: 63–70.

16. Klein, R., Knudtson, M.D. et al.: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXIII the Twenty-five-year Incidence of Macular Edema in Person with Type 1 Diabetes. Ophthalmology, 116, 2010: 497–503.

17. Koleva-Georgieva, D.N., Sivkova, N.P.: Optical Coherence Tomography for the Detection of Early Macular Edema in Diabetic Patients with Retinopathy. Folia Med, 52, 2010: 40–48.

18. Krásný, J., Brunnerová, R. et. al.: Test citlivosti na kontrast v časné detekci očních změn u dětí, dospívajících a mladých dospělých s diabetes mellitus I. typu. Čes a Slov Oftal, 62, 2006: 381–392.

19. Krásný, J., Cihelková, I. et al.: Citlivost na kontrast a fluorescenční angiografie při hodnocení očních změn v rámci posouzení kompenzace diabetes mellitus I. typu u mladých dospělých pacientů. Čes a Slov Oftal, 63, 2007: 17–27.

20. Krasny, J., Andel, M. et al.: The Contrast Sensitivity Test in Early Detection of Ocular Changes in the Relation to the Type 1 Diabetes Mellitus Compensation in Children, Teenagers, and Young Adults. Recent Pat. Inflamm. Alergy Drug Discov, 1, 2007: 232–236.

21. Krásný, J., Vyplašilová, E., et al.: Změna transparence čoček u dětí, mladistvých a mladých dospělých s diabetes mellitus 1. typu. Čes a Slov Oftal, 62, 2006: 304–314.

22. Krásný, J.: Závěrečná zpráva IGA NR/7952 : „Časná detekce klasifikace očních změn u dětí, dospívajících a mladých dospělých s diabetes mellitus 1. typu“.

23. Lopes de Faria, J.M., Katsumi, O. et al.: Neurovisual Abnormalities Preceding the Retinopathy in Patients with Long Term Type 1 Diabetes Mellitus. Graefes Arch Clin Exp Ophthalmol, 239, 2001: 643–648.

24. Martinelli, V., Lacerenza, M. et al.: The Objective Assessment of Visual Contrast Sensivity by Pattern Reversal Visual Evoked Potential in Diabetes. J Diabet Complications, 2, 1988: 44–46.

25. Mortensen, H.B., Hougaard, P.: Comparison of Metabolic Control in a Cross-section Study of 2.873 Children and Adolescents with IDDM from 18 Countries. The HvidØre Study Group on Childhood Diabetes. Diabetes Care, 20, 1997: 714–720.

26. Pelikánová, T.: Novinky v diabetologii. Sborník abstrakt XII. Sympozia: Diabetes mellitus – oční komplikace, UP Olomouc, 2011: 5.

27. Rewers, M., Pihoker, C. et al.: ISPAD Clinical Practice Consensus Guidelines 2009 Compendium Assessment and Monitoring of Glycemic Control in Children and Adolescents with Diabetes. Pediatr Diabet, 10, 2009, (Suppl. No. 12 ): 71–81.

28. Sánchez-Tocino, H., Alvarez-Vidal, A. et al.: Retinal Thickness Study with Optical Coherence Tomography in Pacient with Diabetes. Invest. Ophthalmol Vis Sci, 43, 2002: 1588–1594.

29. Sokol, S., Moskowitz, A. et al.: Contrast Sensivity in Diabetics with and without Background Retinopathy. Arch Ophthalmol, 103, 1985: 51–54.

30. Sosna, T., Bouček, P., Fišer, I.: Diabetická retinopatie, J. Cendelín, 2001, Praha, 255 s. 

31. Sosna, T., Švancarová, R.: Zpráva z EASDec 2011. Sborník abstrakt XII. Sympozia: Diabetes mellitus – oční komplikace, UP Olomouc, 2011: 19–26.

32. Sosna, T., Veith, M.: Zpráva z EASDec 2013. Sborník abstrakt XIV. Sympozia: Diabetes mellitus – oční komplikace, UP Olomouc, 2013: 20–26.

33. Sun, T.S., Zhang, M.N.: Characters of Contrast Sensitivity in Diabetic Patients without Diabetic Retinopathy. Zhonghua Yan Ke Za Zhi. 48, 2012: 41–46.

34. Thomas, M..G., Kumar, A. et al.: Hight Resolution in Vivo Imaging in Achromatopsia. Ophthalmology, 118, 2011: 882–887.

35. Urban, B., Bakunowicz-Lazarcyk, A. et al.: The Evaluation of Contrast Sensivity in Children and Adolescents with Insulin-Dependent Diabetes Mellitus. Klin. Oczna. 101, 1999: 111 – 114.

36. Verrotti, A., Lobefalo, L. et al.: Relationship bettween Contrast Sensivity and Metabolic Control in Diabetics with and without Retinopathy. Ann Med, 30, 1998: 369–374.

37. van Dijk, H.W., Kok, P.H. et al.: Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy. Invest. Ophthalmol Vis Sci, 50, 2009: 3404–3409.

38. Vujosevic, S., Midena, E.: Retinal Layers Changes in Human Preclinical and Early Clinical Diabetic Retinopathy Support Early Neuronal and Müller Cell Alterations.. J. Diabetes Res, 2013, Juny, doi.: 10.1155.

Labels
Ophthalmology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#